RAC 2.20% $1.78 race oncology ltd

Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-132

  1. 146 Posts.
    lightbulb Created with Sketch. 642
    your level of ignorance around the actual rationale behind the formulation change is astounding. Your commitment to the troll is almost impressive, if only you could channel that energy in to trying to poke holes in RAC thesis that are backed by fact and logic.

    When you come up with any please do let us know and we’d be happy to discuss!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.